Lexaria Bioscience Q3 EPS $(0.13) Misses $(0.10) Estimate, Sales $84.00K Miss $150.00K Estimate

Lexaria Bioscience (NASDAQ:LEXX) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.10) by 30 percent. This is a 64.86 percent increase over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $84.00 thousand which missed the analyst consensus estimate of $150.00 thousand by 44.00 percent. This is a 8.10 percent increase over sales of $77.71 thousand the same period last year.